Published in Osteoporos Int on January 01, 2000
Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ (2008) 3.31
Vitamin D insufficiency in a population of healthy western Canadians. CMAJ (2002) 2.73
Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study. Osteoporos Int (2005) 1.80
The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int (2007) 1.64
The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2007) 1.48
Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res (2010) 1.37
Population-based Canadian hip fracture rates with international comparisons. Osteoporos Int (2009) 1.36
Canadian Consensus Conference on osteoporosis, 2006 update. J Obstet Gynaecol Can (2006) 1.33
Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ (2008) 1.33
Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study. Osteoporos Int (2007) 1.26
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int (2010) 1.25
Burden of osteoporosis in adults in Korea: a national health insurance database study. J Bone Miner Metab (2011) 1.23
Prevalence and related risk factors of osteoporosis in peri- and postmenopausal Indian women. J Midlife Health (2011) 1.20
Normative data of bone Mineral Density in healthy population of Tehran, Iran: a cross sectional study. BMC Musculoskelet Disord (2005) 1.18
Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporos Int (2003) 1.17
Prevalence of osteoporosis and reference data for lumbar spine and hip bone mineral density in a Korean population. J Bone Miner Metab (2008) 1.17
Bone mineral density of the spine and femur in healthy Saudis. Osteoporos Int (2004) 1.16
Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res (2009) 1.15
Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health (2012) 1.11
Osteoporosis Canada 2010 guidelines for the assessment of fracture risk. Can Assoc Radiol J (2011) 1.11
Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporos Int (2008) 1.11
Prediction of hip and other osteoporotic fractures from hip geometry in a large clinical cohort. Osteoporos Int (2009) 1.03
Population-based reference values for bone mineral density in young men. Osteoporos Int (2007) 1.02
Bone mineral density reference ranges for Australian men: Geelong Osteoporosis Study. Osteoporos Int (2009) 1.02
Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk. J Bone Miner Res (2009) 1.00
Geographic variation of bone mineral density and selected risk factors for prediction of incident fracture among Canadians 50 and older. Bone (2008) 1.00
Bone mineral density reference norms for Hong Kong Chinese. Osteoporos Int (2005) 1.00
Reference values of bone mineral density and prevalence of osteoporosis in Chinese adults. Osteoporos Int (2013) 1.00
Bone mineral density predicts osteoporotic fractures in elderly men: the MINOS study. Osteoporos Int (2005) 1.00
A novel diagnostic tool reveals mitochondrial pathology in human diseases and aging. Aging (Albany NY) (2013) 0.99
Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in mainland Chinese women and the diagnosis of osteoporosis. Osteoporos Int (2003) 0.94
Bone mineral density at the hip in Norwegian women and men--prevalence of osteoporosis depends on chosen references: the Tromsø Study. Eur J Epidemiol (2009) 0.93
Performance of comorbidity measures for predicting outcomes in population-based osteoporosis cohorts. Osteoporos Int (2011) 0.92
Independent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture. CMAJ (2010) 0.92
Prevalence of osteoporosis and incidence of hip fracture in women--secular trends over 30 years. BMC Musculoskelet Disord (2010) 0.92
Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study. BMC Musculoskelet Disord (2010) 0.90
Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS). Osteoporos Int (2003) 0.89
Genome-wide association study for radiographic vertebral fractures: a potential role for the 16q24 BMD locus. Bone (2014) 0.88
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2006) 0.88
Quality of fracture risk assessment in post-fracture care in Ontario, Canada. Osteoporos Int (2012) 0.88
A Frailty Index predicts 10-year fracture risk in adults age 25 years and older: results from the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2014) 0.88
Validation of a case definition for osteoporosis disease surveillance. Osteoporos Int (2010) 0.88
Association between osteoporosis and urinary calculus: evidence from a population-based study. Osteoporos Int (2012) 0.87
Relationship of nutrient intakes and bone mineral density of elderly women in Daegu, Korea. Nutr Res Pract (2007) 0.87
Femoral and whole-body bone mineral density in middle-aged and older Norwegian men and women: suitability of the reference values. Osteoporos Int (2004) 0.87
Association between osteoporosis and psoriasis: results from the Longitudinal Health Insurance Database in Taiwan. Osteoporos Int (2012) 0.85
Clinical nutrition: 2. The role of nutrition in the prevention and treatment of adult osteoporosis. CMAJ (2001) 0.84
Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis. J Neurol (2009) 0.84
Direct-to-participant feedback and awareness of bone mineral density testing results in a population-based sample of mid-aged Canadians. Osteoporos Int (2009) 0.83
An osteoporosis screening tool for Chinese men. Osteoporos Int (2004) 0.83
Treatment of osteoporosis in an older home care population. BMC Musculoskelet Disord (2005) 0.82
Assessment of determinants for osteoporosis in elderly men. Osteoporos Int (2008) 0.82
Fracture risk prediction: importance of age, BMD and spine fracture status. Bonekey Rep (2013) 0.81
Prevalence of osteoporosis in men and determinants of changes in bone mass in a non-selected Spanish population. Osteoporos Int (2004) 0.81
The early onset of disease may be a risk factor for decreased bone mineral density in patients with inflammatory bowel disease. Clin Endosc (2013) 0.81
Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study. Osteoporos Int (2005) 0.81
Prevalence and risk factors of distal radius and calcaneus bone mineral density in Korean population. Osteoporos Int (2004) 0.81
Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol (2015) 0.80
Risk factors for bone mineral density at the calcaneus in 40-59 year-old male workers: a cross-sectional study in Korea. BMC Public Health (2008) 0.80
Predicting fracture using 2D finite element modelling. Med Eng Phys (2011) 0.79
The efficacy and safety of a combined alendronate and calcitriol agent (maxmarvil): a postmarketing surveillance study in korean postmenopausal women with osteoporosis. Korean J Fam Med (2012) 0.78
Complementary and alternative medicine use by osteoporosis clinic patients. Osteoporos Int (2007) 0.78
Trabecular Bone Score and Incident Fragility Fracture Risk in Adults with Reduced Kidney Function. Clin J Am Soc Nephrol (2016) 0.78
Perimenopausal and Postmenopausal Health. BMC Womens Health (2004) 0.78
Review of the safety and efficacy of risedronate for the treatment of male osteoporosis. Clin Interv Aging (2007) 0.78
Effects of the sample size of reference population on determining BMD reference curve and peak BMD and diagnosing osteoporosis. Osteoporos Int (2007) 0.77
Risk factors of osteoporosis in healthy Moroccan men. BMC Musculoskelet Disord (2010) 0.77
Determining whether women with osteopenic bone mineral density have low, moderate, or high clinical fracture risk. Menopause (2010) 0.77
Validation of a decision model for preventive pharmacological strategies in postmenopausal women. Eur J Epidemiol (2005) 0.76
Relationship between calcaneal quantitative ultrasound and hip dual energy X-ray absorptiometry in young healthy men. Osteoporos Int (2012) 0.76
Bone mineral density and osteoporosis among a predominantly Caucasian elderly population in the city of São Paulo, Brazil. Osteoporos Int (2005) 0.76
The effects of the Korean reference value on the prevalence of osteoporosis and the prediction of fracture risk. BMC Musculoskelet Disord (2015) 0.75
Incidence and excess mortality of hip fracture in young adults: a nationwide population-based cohort study. BMC Musculoskelet Disord (2016) 0.75
EXACT: exercise or advice after ankle fracture. Design of a randomised controlled trial. BMC Musculoskelet Disord (2011) 0.75
Bone mineral densities in individuals with Gilbert's syndrome: a cross-sectional, case-control pilot study. Can J Gastroenterol (2009) 0.75
Prevalence and determinants of osteoporosis among men aged 50 years or more in Sri Lanka: a community-based cross-sectional study. Arch Osteoporos (2009) 0.75
Utilization of bone mineral density testing among breast cancer survivors in British Columbia, Canada. Osteoporos Int (2017) 0.75
Elevated bone mass: a weighty matter? Skeletal Radiol (2008) 0.75
Prevalence of low central bone mineral density in a Bulgarian female referral population: a pilot study. Rheumatol Int (2005) 0.75
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet (1995) 7.17
Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17
Analysis of 1.9 Mb of contiguous sequence from chromosome 4 of Arabidopsis thaliana. Nature (1998) 5.91
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery. Arthritis Rheum (1999) 4.46
Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med (1995) 3.92
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
Placing trials in context using Bayesian analysis. GUSTO revisited by Reverend Bayes. JAMA (1995) 3.73
Mortality in systemic lupus erythematosus. Arthritis Rheum (2006) 3.61
Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. Arthritis Rheum (1996) 3.40
Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. BMJ (1995) 3.40
Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med (1987) 3.13
Bayesian interim statistical analysis of randomised trials. Lancet (1997) 3.06
DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet (1984) 2.92
Birth of a biome: insights into the assembly and maintenance of the Australian arid zone biota. Mol Ecol (2008) 2.73
Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests. Biometrics (2001) 2.72
Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry. JAMA (2001) 2.70
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
First direct observation of a nearly ideal graphene band structure. Phys Rev Lett (2009) 2.41
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Antidepressant medication use and breast cancer risk. Am J Epidemiol (2000) 2.29
The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol (1994) 2.23
Effectiveness of a training program in reducing infections in toddlers attending day care centers. Epidemiology (1999) 2.21
Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology (1982) 2.21
Factors determining conversion to laparotomy in patients undergoing laparoscopic cholecystectomy. Am J Surg (1994) 2.16
Extracorporeal photopheresis in the treatment of AIDS-related complex: a pilot study. Ann Intern Med (1990) 2.08
Myosin conformational states determined by single fluorophore polarization. Proc Natl Acad Sci U S A (1998) 2.07
Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review. BJOG (2013) 2.06
Parathyroid hormone: secretion and metabolism in vivo. Proc Natl Acad Sci U S A (1971) 2.04
Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate. J Clin Endocrinol Metab (2000) 2.00
Amino-acid sequence of equine renal metallothionein-1B. Proc Natl Acad Sci U S A (1976) 1.99
Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases. N Engl J Med (1973) 1.99
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int (1999) 1.98
The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity. JAMA (1992) 1.98
Cancer registration in Ontario: a computer approach. IARC Sci Publ (1991) 1.97
An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum (2005) 1.96
Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ (2000) 1.94
Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med (2001) 1.93
A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Lupus (1998) 1.93
Why multilayer graphene on 4H-SiC(0001[over ]) behaves like a single sheet of graphene. Phys Rev Lett (2008) 1.92
Estimating the sensitivity and specificity of Kato-Katz stool examination technique for detection of hookworms, Ascaris lumbricoides and Trichuris trichiura infections in humans in the absence of a 'gold standard'. Int J Parasitol (2009) 1.88
Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev (2012) 1.88
Inactivation of viruses and bacteria by ozone, with and without sonication. Appl Microbiol (1975) 1.88
Consent to the use of stored DNA for genetics research: a survey of attitudes in the Jewish population. Am J Med Genet (2001) 1.87
The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2008) 1.86
Augmented trochanteric bone mineral density after modified physical education classes: a randomized school-based exercise intervention study in prepubescent and early pubescent children. J Pediatr (2000) 1.85
Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2001) 1.83
Estimation of direct and indirect costs because of common infections in toddlers attending day care centers. Pediatrics (1999) 1.83
Spatial relationships in early signaling events of flow-mediated endothelial mechanotransduction. Annu Rev Physiol (1997) 1.81
Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol (1992) 1.75
The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy (2000) 1.70
Routine immunologic tests in systemic lupus erythematosus: is there a need for more studies? J Rheumatol (1996) 1.67
Scalable templated growth of graphene nanoribbons on SiC. Nat Nanotechnol (2010) 1.66
Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke (2004) 1.66
Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res (1988) 1.66
Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems. J Am Coll Cardiol (1996) 1.65
Antimalarial drug utilization by women in Ethiopia: a knowledge-attitudes-practice study. Bull World Health Organ (1993) 1.62
Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol (2011) 1.62
Socioeconomic status and indicators of asthma in children. Am J Respir Crit Care Med (1995) 1.61
Agreement in measuring socio-economic status: area-based versus individual measures. Chronic Dis Can (2000) 1.61
Termination of mammalian rDNA replication: polar arrest of replication fork movement by transcription termination factor TTF-I. Cell (1997) 1.61
An epidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol (1982) 1.60
[Specific interference with development and plastid enzyme formation in higher plants by elevated growth temperature]. Z Naturforsch B (1969) 1.60
Comparison of self-reported and physician-reported antidepressant medication use. Ann Epidemiol (1999) 1.60
Life expectancy following dietary modification or smoking cessation. Estimating the benefits of a prudent lifestyle. Arch Intern Med (1994) 1.59
Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). Prev Med (1998) 1.55
Prevalence of IgA-antiendomysial antibody in asymptomatic low bone mineral density. Am J Gastroenterol (2001) 1.54
Parathyroid hormone: sequence, synthesis, immunoassay studies. Am J Med (1971) 1.53
Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer (2000) 1.52
Photopheresis for the treatment of cutaneous T cell lymphoma. J Am Acad Dermatol (1990) 1.49
A comparison of parametric and nonparametric approaches to ROC analysis of quantitative diagnostic tests. Med Decis Making (1997) 1.49
The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2007) 1.48
The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2003) 1.47
Kinetics of folding of leucine zipper domains. Biochemistry (1995) 1.47
Placenta previa: preponderance of male sex at birth. Am J Epidemiol (1999) 1.47
Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials. Osteoporos Int (2014) 1.45
The SCARF osteotomy for the correction of hallux valgus deformities. Foot Ankle Int (2002) 1.45
Acute fulminant hepatitis after treatment with rabeprazole and terbinafine. Arch Intern Med (2001) 1.42
Cholesterol screening of children at high risk: behavioural and psychological effects. CMAJ (1997) 1.41
Does the use of low-level laser influence wound healing in chronic venous leg ulcers? J Wound Care (2005) 1.41
Chimerism does not predict for outcome after alemtuzumab based conditioning. Bone Marrow Transplant (2007) 1.40
Current status of whole-body counting as a means to detect and quantify previous exposures to radioactive materials. Whole-body Counting Working Group. Health Phys (1991) 1.39
Molecular pathogenesis of Epstein-Barr virus associated posttransplant lymphomas: new insights through latent membrane protein 1 fingerprinting. Transplantation (2001) 1.39
Dialysis staff influence patients in formulating their advance directives. Am J Kidney Dis (1995) 1.39